ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

NCI Breast Cancer Overview Report Competed

August 5, 1988

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

Henry Neil, Natcher’s right arm, Back In The Job

March 25, 1988

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996